Skip to main content

Peer Review reports

From: Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma

Original Submission
30 Mar 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
23 May 2022 Reviewed Reviewer Report
27 May 2022 Reviewed Reviewer Report
5 Jun 2022 Author responded Author comments - Hongchun Liu
Resubmission - Version 4
5 Jun 2022 Submitted Manuscript version 4
6 Jun 2022 Author responded Author comments - Hongchun Liu
Resubmission - Version 5
6 Jun 2022 Submitted Manuscript version 5
19 Jun 2022 Reviewed Reviewer Report
10 Jul 2022 Author responded Author comments - Hongchun Liu
Resubmission - Version 6
10 Jul 2022 Submitted Manuscript version 6
21 Jul 2022 Author responded Author comments - Hongchun Liu
Resubmission - Version 7
21 Jul 2022 Submitted Manuscript version 7
26 Jul 2022 Author responded Author comments - Hongchun Liu
Resubmission - Version 8
26 Jul 2022 Submitted Manuscript version 8
Publishing
2 Aug 2022 Editorially accepted
13 Aug 2022 Article published 10.1186/s12885-022-09987-2

You can find further information about peer review here.

Back to article page